In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...